Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story

LOS ANGELES, July 15, 2011 /PRNewswire/ -- The current issue of Popular Science magazine includes a feature story profiling William H. Andrews, a member of the Genesis Biopharma, Inc. (OTC/BB: GNBP) Board of Directors, and his work on the anti-aging properties of the human telomerase gene.

The entire 11-page story, titled "The Man Who Would Stop Time" by Joseph Hooper, can be found at www.popsci.com

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer therapies. For more information about the company, visit www.genesis-biopharma.com.

SOURCE Genesis Biopharma, Inc.